|
rs3093023 |
SNP |
PedAM |
snpId=rs3093023; pubmedId=21120996; geneId=7128; geneSymbol=TNFAIP3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Conversely, 3 of the 27 SNPs (CCR6 rs3093023, TAGAP rs394581, and TNFAIP3 rs6920220) demonstrated ORs in the opposite direction from those reported for RA patients of European ancestry.; score=0.167568474; Year=2010; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167120802; REF=G; ALT=A |
details
|
|
|
rs3093023 |
SNP |
PedAM |
snpId=rs3093023; pubmedId=23678157; geneId=3119; geneSymbol=HLA-DQB1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Among these associations, we found that 8 single-nucleotide polymorphisms (SNP; rs1600249, rs2736340, rs3093023, rs3093024, rs4810485, rs615672, rs660895, and rs9272219) serve as cis-effect regulators of the corresponding eQTL genes (BLK and CD4 in non-HLA region; CCR6, HLA-DQA1, and HLA-DQB1 in HLA region) that also were differentially expressed in RA-related cell groups.; score=0.051226702; Year=2014; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167120802; REF=G; ALT=A |
details
|
|
|
rs3093023 |
SNP |
PedAM |
snpId=rs3093023; pubmedId=20453842; geneId=1235; geneSymbol=CCR6; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.; score=0.252539865; Year=2010; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167120802; REF=G; ALT=A |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=23577190; geneId=10678; geneSymbol=B3GNT2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.123181358; Year=2013; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=20453841; geneId=1235; geneSymbol=CCR6; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility.; score=0.252539865; Year=2010; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=23577190; geneId=1437; geneSymbol=CSF2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.129424521; Year=2013; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=23577190; geneId=7128; geneSymbol=TNFAIP3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.167568474; Year=2013; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=23577190; geneId=5771; geneSymbol=PTPN2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.248458305; Year=2013; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=23678157; geneId=3119; geneSymbol=HLA-DQB1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Among these associations, we found that 8 single-nucleotide polymorphisms (SNP; rs1600249, rs2736340, rs3093023, rs3093024, rs4810485, rs615672, rs660895, and rs9272219) serve as cis-effect regulators of the corresponding eQTL genes (BLK and CD4 in non-HLA region; CCR6, HLA-DQA1, and HLA-DQB1 in HLA region) that also were differentially expressed in RA-related cell groups.; score=0.051226702; Year=2014; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=23577190; geneId=84159; geneSymbol=ARID5B; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242909916; Year=2013; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=23577190; geneId=116985; geneSymbol=ARAP1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.000271442; Year=2013; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=23577190; geneId=122618; geneSymbol=PLD4; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242638474; Year=2013; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=23678157; geneId=3118; geneSymbol=HLA-DQA2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Among these associations, we found that 8 single-nucleotide polymorphisms (SNP; rs1600249, rs2736340, rs3093023, rs3093024, rs4810485, rs615672, rs660895, and rs9272219) serve as cis-effect regulators of the corresponding eQTL genes (BLK and CD4 in non-HLA region; CCR6, HLA-DQA1, and HLA-DQB1 in HLA region) that also were differentially expressed in RA-related cell groups.; score=0.123452799; Year=2014; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=20453841; geneId=1235; geneSymbol=CCR6; diseaseId=umls:C0003873; sourceId=GAD; sentence=[A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility.]; score=0.252539865; Year=2010; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=23577190; geneId=306; geneSymbol=ANXA3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242638474; Year=2013; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=23577190; geneId=9308; geneSymbol=CD83; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.123267234; Year=2013; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=23577190; geneId=9034; geneSymbol=CCRL2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.005710211; Year=2013; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093024 |
SNP |
PedAM |
snpId=rs3093024; pubmedId=23678157; geneId=640; geneSymbol=BLK; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Among these associations, we found that 8 single-nucleotide polymorphisms (SNP; rs1600249, rs2736340, rs3093023, rs3093024, rs4810485, rs615672, rs660895, and rs9272219) serve as cis-effect regulators of the corresponding eQTL genes (BLK and CD4 in non-HLA region; CCR6, HLA-DQA1, and HLA-DQB1 in HLA region) that also were differentially expressed in RA-related cell groups.; score=0.128458305; Year=2014; geneSymbol_dbSNP=CCR6;LOC105378122; CHROMOSOME=6; POS=167119305; REF=A; ALT=G |
details
|
|
|
rs3093457 |
SNP |
PedAM |
snpId=rs3093457; pubmedId=19723899; geneId=1421; geneSymbol=CRYGD; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Two SNP were associated with RA in the joint analysis of all samples: rs6520278 (TIMP1) was associated with RA in general (p = 0.035) and rs3093457 (IL9R) with anti-CCP-positive RA patients (p = 0.037) and male RA patients (p = 0.010).; score=0.021986792; Year=2009; geneSymbol_dbSNP=IL9R; CHROMOSOME=Y;X; POS=57184462;155997942; REF=T; ALT=G |
details
|
|
|
rs3125734 |
SNP |
PedAM |
snpId=rs3125734; pubmedId=23028356; geneId=219790; geneSymbol=RTKN2; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Functional variants in NFKBIE and RTKN2 involved in activation of the NF-¦ÊB pathway are associated with rheumatoid arthritis in Japanese.; score=0.120271442; Year=2012; geneSymbol_dbSNP=RTKN2; CHROMOSOME=10; POS=62198353; REF=T; ALT=C |
details
|
|
